NEW YORK (Reuters Health) – The results of a small trial suggest that vitamin B12 is a safe, effective, and inexpensive treatment for recurrent aphthous stomatitis (RAS). “The…
NEW YORK (Reuters Health) – After pregnancy, women with multiple sclerosis may substantially reduce their risk of relapses if they breastfeed their infants, without adding supplemental formula feedings,…
NEW YORK (Reuters Health) – The risk of visual field loss with the antiepileptic drug vigabatrin is lower when it is given during infancy rather than later in…
NEW YORK (Reuters Health) – Fewer than 1% of adolescents in the US are potential candidates for cholesterol-lowering agents, based on updated guidelines released last year by the…
NEW YORK (Reuters Health) – In patients with rheumatoid arthritis, anti-tumor necrosis factor (TNF) treatment with adalimumab and infliximab is associated with a small increased risk of herpes…
NEW YORK (Reuters Health) – In a study of healthy adolescents, a quadrivalent meningococcal glycoconjugate vaccine was more immunogenic than the currently licensed unconjugated vaccine. Adolescents are at…
NEW YORK (Reuters Health) – New research suggests that B-cell clones may be a useful early marker for chronic lymphocytic leukemia (CLL) since they are found in nearly…
NEW YORK (Reuters Health) – In patients with diffuse cutaneous systemic sclerosis (dcSSc), treatment with rituximab depletes B cells in the peripheral circulation and in skin, with few…
NEW YORK (Reuters Health) – In premenopausal women with endocrine-responsive early breast cancer, addition of the bisphosphonate zoledronic acid to endocrine therapy significantly improves disease-free survival, physicians in…
NEW YORK (Reuters Health) – New research suggests that migraine is a risk factor for hypertensive disorders during pregnancy, including gestational hypertension and preeclampsia. The findings, which appear…
